Undecimal Bio has closed an oversubscribed Seed financing round of $18 million. The funding will be used to expand its AI-enabled platform for targeted siRNA therapeutic delivery.
Amount Raised
$18 Million
Round Type
Seed
Description
Undecimal Bio, a spin-out from Eleven Therapeutics, announced the launch of its platform biotechnology company with an $18 million seed financing. The funding is aimed at enhancing DELiveri®, its proprietary platform that targets RNA medicines to specific cell types. This innovation seeks to address significant challenges in genetic medicine delivery. The oversubscribed round highlights strong investor interest in advancing siRNA therapeutics.
Quick answer
Undecimal Bio raised $18 Million in a Seed round, dated October 13, 2026.
- How much did Undecimal Bio raise?
- Undecimal Bio raised $18 Million in a Seed round on October 13, 2026.
- What does Undecimal Bio do?
- Undecimal Bio is a platform biotechnology company focused on advancing targeted delivery of siRNA therapeutics.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Undecimal Bio that raised within 45 days of this round, from Fundz verified event records.
- Lifeplex Science raised $5.3M (Series A) on November 13, 2026.
- Orakl Oncology raised $34M (Series A) on November 12, 2026.
- VectorY raised $83M on November 11, 2026.
- Neurosterix raised $105M (Series B) on November 11, 2026.
- Oyster Therapeutics raised $60M (Series A) on November 10, 2026.
- SRTD biotech raised $35M (Seed) on November 9, 2026.
Who to call at Undecimal Bio, and when
A new round usually means Undecimal Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Undecimal Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Undecimal Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Undecimal Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Undecimal Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Undecimal Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.